HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,000 | +100.0% | 1,621 | +50.0% | 0.00% | – |
| Q3 2016 | $2,000 | -33.3% | 1,081 | +15.4% | 0.00% | – |
| Q2 2016 | $3,000 | -90.0% | 937 | -91.1% | 0.00% | – |
| Q1 2016 | $30,000 | -38.8% | 10,518 | -7.0% | 0.00% | – |
| Q4 2015 | $49,000 | -40.2% | 11,304 | +5.4% | 0.00% | – |
| Q3 2015 | $82,000 | -26.1% | 10,726 | +7.9% | 0.00% | – |
| Q2 2015 | $111,000 | – | 9,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,758,426 | $3,340,000 | 2.33% |
| PERKINS CAPITAL MANAGEMENT INC | 2,527,000 | $1,774,000 | 1.59% |
| Cowen Prime Services LLC | 2,137,900 | $1,501,000 | 0.69% |
| HighMark Wealth Management LLC | 192,000 | $134,000 | 0.14% |
| Nantahala Capital Management | 5,000,000 | $3,510,000 | 0.11% |
| Kalos Management, Inc. | 66,900 | $48,000 | 0.02% |
| FNY Investment Advisers, LLC | 20,500 | $14,000 | 0.00% |
| Virtu Financial LLC | 31,991 | $22,000 | 0.00% |
| Engineers Gate Manager LP | 25,440 | $18,000 | 0.00% |
| BlackRock Inc. | 405,725 | $285,000 | 0.00% |